FDA must prove fraud in Vioxx suits
James G. Dickinson
June 01 2007
Dealing a severe blow to more than a 1,000 Texas product liability cases involving Merck’s Cox-2 selective inhibitor Vioxx, a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.